TrialHaemophilia : the official journal of the World Federation of Hemophilia2015

Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients.

U Martinowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.